Kelvin Kwan N. Lau, MD, Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective to Reuters Health on a medical records analysis published in the Journal of the American College of Surgeons that showed the Albumin-Bilirubin (ALBI) score more accurately predicted outcomes in patients undergoing pulmonary, elective colorectal and adrenal operations than the Model for End Stage Liver Disease-sodium (MELD-Na). Dr. Lau is the study’s corresponding author. MD Alert and Medscape picked up the Reuters Health article.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH